NBS superfood: a promising adjunctive therapy in critically ill ICU patients with omicron variant of COVID-19
Description
This clinical trial aimed to assess the impact of Nutrition Bio-shield superfood (NBS) on clinical status among critically ill ICU patients suffering from acute respiratory distress syndrome (ARDS) due to the Omicron variant of COVID-19. A total of
